Initiating clinical studies can be challenging and even more so when you are a small or new biotech. Turn to Catalent Biologics, a trusted sterile fill/finish partner for an efficient orchestration of your project with the right scale for your Phase 1 and 2 needs. https://ow.ly/Opac50TaZst
Catalent Pharma Solutions
制药业
Somerset，NJ 271,618 位关注者
more products. better treatments. reliably supplied. ?
关于我们
Catalent Inc. (NYSE: CTLT), an S&P 500? company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown to become a community of approximately 19,000+ workers who support over 7,000 products for over 1,000 customers around the world. We share a common goal: to put patients first and help people around the world live better and healthier lives. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results. more products. better treatments. reliably supplied.? Your talents, ideas, and passion are essential to our mission: to develop, manufacture, and supply products that help people live better, healthier lives. Join us! Catalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech, and healthcare companies, will help bring life-enhancing products to life. Grow with us. Be challenged. Make a personal impact. Visit https://careers.catalent.com/us/en to explore career opportunities
- 网站
-
https://www.catalent.com
Catalent Pharma Solutions的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Somerset，NJ
- 类型
- 上市公司
- 创立
- 2007
- 领域
- Analytical Chemistry、Clinical Supply、Biotech、Pharmaceutical Supply Chain、Biologics、Formulation Development、Drug Delivery、Clinical Packaging、Dose Form Manufacturing、Gene Therapy、Vaccine Production、Pharmaceutical、Drug Development、Cell Therapy、Biopharmaceutical和Innovation
地点
Catalent Pharma Solutions员工
动态
-
Charged variant analysis is an important tool to understand the bio-functionality of biologics. In this on-demand webinar, Catalent experts discuss challenges involved with the isolation, purification and characterization of charged variants of biotherapeutics, including monoclonal antibodies and fusion proteins. https://ow.ly/zVRP50U0GvC
-
-
David McErlane, Group President of Biologics, and Aris Gennadios, Group President of Pharma and Consumer Health, share their expert views on how Catalent has forged long-term collaborations and partnerships that drive innovation in the CDMO space. Their insights are featured in a recent article by CHEManager which dives into the latest trends shaping the industry, including advanced manufacturing technologies, new regulatory shifts, and the growing emphasis on sustainability. Read the article here: https://ow.ly/RAvf50TE8F7 #CDMO #Pharma #Biotech #Manufacturing #Innovation #Sustainability
-
-
Join industry experts Nathalie Clément from Siren Biotechnology and George Buchman PhD from Catalent as they share insights on how leveraging platform processes can expedite the development of novel gene and cancer therapies, bringing them faster to the clinic. https://ow.ly/ackA50U9tnW
-
-
The Catalent Inhalation team is thrilled to be at Drug Delivery to the Lungs Conference (DDL) in Edinburgh! Swing by booth #205 to discuss how Catalent can support your pulmonary or nasal development and manufacturing needs. Schedule a meeting today! https://ow.ly/yNZi50U1jGf
-
-
In this executive summary, Catalent expert Nicole Gray shares her experience of decentralized trials, highlighting how clinical supply can be scaled up as trial phases progress, and technological solutions for accelerated trial deployment. https://ow.ly/OIWw50U0SIn
-
-
Explore the critical aspects of lipid-based formulations, from preclinical studies to clinical applications and delve into the various mechanisms through which these formulations exert their effects. Watch this webinar now. https://ow.ly/2HL250U9iAF
-
-
Catalent is helping transform lab innovations into therapies that impact lives. Catalent’s Frederic Cedrone spoke to Blake Forman from Technology Networks Blog about the journey of iPSC-based cell therapies from discovery to patient care. https://ow.ly/n1mU50Ue7AI #CellTherapy #iPSC #PatientFirst
-
-
Optimize your analytical strategies throughout the Biologics Development Life Cycle process & drive production efficiency and deliver high-quality therapeutics to patients faster. #Biologics #BiologicsCDMO #AnalyticalDevelopment https://ow.ly/IFav50TZPSV
-
-
It’s nearly the end of 2024, meaning it’s time to vote for The Medicine Maker Company of the Year Awards! Vote for Catalent: https://ow.ly/flyV50U7SVs
-